osocimab   Click here for help

GtoPdb Ligand ID: 11366

Synonyms: BAY 1213790 | BAY-1213790 | BAY1213790
Compound class: Antibody
Comment: Osocimab (BAY 1213790) is a fully humanized monoclonal antibody that targets activated Factor XI [1]. It is being investigated for clinical prevention of thrombosis [2].
Click here for help
No information available.
Summary of Clinical Use Click here for help
Osocimab has been advanced to clinical trial for prevention of thrombosis in select patient groups [2].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03276143 FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty Phase 2 Interventional Bayer Compared with enoxaparin, osocimab met criteria for superiority in preventing post-operative venous thromboembolism. 2
NCT04523220 Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis Phase 2 Interventional Bayer